Latest market price
17.47
-0.36-2.02%
OverviewShort InterestFilings
JANXQT37Janux Therapeutics, Inc.·NASDAQ
17.47-2.02%

Latest SEC Filings

Form category
DescriptionFilingDocument
Aug 14, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 13, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 06, 202610-QQuarterly report
Aug 06, 20268-KCurrent report
Jul 31, 20264Statement of changes in beneficial ownership
Jul 28, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Jul 10, 20264Statement of changes in beneficial ownership
Jun 23, 20268-KCurrent report
Jun 12, 20264Statement of changes in beneficial ownership
Jun 12, 20264Statement of changes in beneficial ownership
Jun 12, 20264Statement of changes in beneficial ownership
Jun 12, 20268-KCurrent report
Jun 12, 20264Statement of changes in beneficial ownership
Jun 12, 20264Statement of changes in beneficial ownership
Jun 12, 20264Statement of changes in beneficial ownership
Jun 12, 20264Statement of changes in beneficial ownership
Jun 04, 20264Statement of changes in beneficial ownership
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 13, 20264Statement of changes in beneficial ownership
May 12, 2026SC 13GBeneficial ownership statement (passive)
May 07, 202610-QQuarterly report
May 07, 20268-KCurrent report
May 06, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Apr 29, 2026SC 13GBeneficial ownership statement (passive)
Apr 29, 2026SC 13GBeneficial ownership statement (passive)
#1 / 25 of 298
Page
▼
/ 12